Мы разошлем вашу новость, анонс или пресс-релиз в более 1000 СМИ
Мы опубликуем вашу новость в самых авторитетных и профильных изданиях России и СНГ
Предоставим подробный отчет, с ссылками на все публикации
Популярные новости
06.04.2018 Медицина и фармацевтика
Non-Invasive Prenatal Testing Market is Driven by Increasing Healthcare Expenditure
The global non-invasive prenatal testing (NIPT) market was valued at $563.4 million in 2014, and it is expected to grow with a CAGR of 17.6% during the period 2015 - 2020.
The global NIPT market is growing, due to increasing healthcare expenditure. The average maternal age is increasing in high income countries, due to changing pattern of employment, education and marriage, and increasing cost of raising a child.
Explore Report Description With Detailed TOC on "Global NIPT Market” at: https://www.psmarketresearch.com/market-analysis/non-invasive-prenatal-testing-market
Based on test type, the MaterniT21 PLUS segment led the global NIPT market in 2014 with the largest market size. It was the first test introduced in the market for the diagnosis of Trisomy 21, in 2011. However, the NIFTY test segment is expected to grow with the fastest rate, among the various test type segments during the forecast period.
Download Report Sample at: https://www.psmarketresearch.com/market-analysis/non-invasive-prenatal-testing-market/report-sample
However, certain restraints such as strict regulatory requirements and ethical hurdles are hindering the growth of the market. The increasing awareness about NIPT and improving healthcare facilities in developing countries, such as China and India, are laying significant growth opportunities for NIPT market. The Asia-Pacific market is expected to witness the fastest growth (CAGR 18.1%) globally during the period 2015 – 2020.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=non-invasive-prenatal-testing-market
The key companies operating in the global NIPT market include Sequenom Inc., BGI, LifeCodexx AG, Quest Diagnostics Incorporated, Hoffmann-La Roche Ltd., Illumina Inc., Berry Genomics Co. Ltd., Laboratory Corporation of America Holdings, and Natera Inc.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
